Abstract

Introduction/Objective Even during the coronary virus disease (COVID-19) pandemic, patients can develop symptoms of acute myocardial infarction with ST elevation (STEMI). We are presenting the case of a COVID-19 positive patient with STEMI diagnosed in a prehospital setting, with differential diagnosis questions during hospitalization and implementation of high personal protection standards by medical staff during his treatment. Case report on 4th April 2020, at 12.26 A.M. a medical emergency team was dispatched to transport a 51-year-old male patient from the Vozdovac Community Health Center infirmary to a catheterization lab for a possible STEMI. Upon arrival at 12.39 P.M., the patient complained of retrosternal chest pain that he described as an 8/10 in severity. The pain commenced two hours earlier at rest. He did not have a respiratory infection and the epidemiological survey for COVID-19 was negative. On examination, he was conscious, oriented, communicative, subfebrile (37.1°C), normotensive (130/70mmHg), eupneic (18 breaths/min), with normal auscultatory breath sounds and a blood oxygen saturation level of 98%. Heart sounds are of regular rate (62 bpm) and rhythm, with no murmurs and no signs of decompensation. The electrocardiography (ECG) recorded at the Health Centre showed an ST elevation in lateral leads, which was confirmed on the ECG recorded by the emergency medical system (EMS). An IV catheter was placed and dual antiplatelet therapy was administered. At the Institute for Cardiovascular Diseases Dedinje, a SARS-COV-2 IgG/IgM rapid test showed that the patient was positive for Coronavirus. Arrangements were made and at 1 P.M. the hemodynamically stable patient was transported directly to the COVID-19 "Dr Dragiša Mišović" hospital catheterization lab. Along with STEMI, the differential diagnosis included myocardial infarction with nonobstructive coronary arteries (MINOCA), pulmonary embolism and myopericarditis, which were excluded after performing coronary angiography, echocardiography and computed tomography pulmonary artery angiography. While treating the patient, the medical staff on all levels used the recommended personal protective equipment. During hospitalization, the patient was hemodynamically stable with no rhythm abnormalities, eupneic, with blood oxygen saturation level ranging from 98-100% on room oxygen. The control nasopharyngeal swab came back SARS Cov2 negative on 5th May 2020. COVID-19 specific therapy was administered. The patient was discharged from the hospital with prescribed cardiac medication. He was ordered to self-isolate at home for 14 days, at which time another control swab would be taken. Conclusion Sometimes, a STEMI diagnosed in the prehospital setting does not represent the final diagnosis and it is necessary to take into consideration other differential diagnostic possibilities. A high level of safety strategy for all medical personnel is recommended on all levels when treating patients.

Highlights

  • The cause of coronary virus disease (COVID-19) pandemic is a newly discovered severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that has been shown to cause potentially lethal forms of the disease

  • We are presenting the case of a COVID-19 positive patient with a STEMI diagnosed in prehospital settings, with differential diagnosis questions during hospitalization and implementation of high personal protection standards by medical staff during his treatment

  • Case report On 4th April 2020, at 12.26 A.M. a medical emergency team was dispatched to transport a 51-yearold male patient from the Vozdovac Community Health Center infirmary to a catheterization lab for a possible a acute myocardial infarction with ST elevation (STEMI)

Read more

Summary

Conclusion

Patients can develop symptoms of STEMI even during the COVID-19 pandemic. 2. Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, et al Management of Acute Myocardial Infarction During the COVID-19 Pandemic. It Appears in COVID-19 - Nonobstructive disease dominates but mortality is high, New York hospitals report. 6. 2020 ESC Guidance for the Diagnosis and Management of CV Disease in the Context of the COVID-19. ECDC technical report- Infection prevention and control for COVID-19 in healthcare settings - first update 12 March 2020 (March 12, 2020; date last accessed). Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test [news release]. Prikazujemo COVID-19 pozitivnog pacijenta sa prehospitalno detektovanim STEMI, diferencijalno dijagnostičkim nedoumicama tokom hospitalizacije i primeni strategije visokog nivoa bezbednosti zdravstvenih radnika tokom njegovog zbrinjavanja. Ključne reči: pandemija, COVID-19, STEMI, diferencijalna dijagnoza, bezbednost, zdravstveni radnici

Introduction
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.